Romano Antonio, Viola Marinella, Mondino Chiara, Pettinato Rosa, Di Fonso Maina, Papa Giuseppe, Venuti Alberto, Montuschi Paolo
Department of Internal Medicine and Geriatrics, UCSC Allergy Unit, Complesso Integrato Columbus, Rome, Italy.
Int Arch Allergy Immunol. 2002 Oct;129(2):169-74. doi: 10.1159/000065876.
Maculopapular and urticarial rashes are nonimmediate manifestations common during penicillin treatment; the former often represent cell-mediated hypersensitivity. Our objectives were to assess the incidence of allergy in adults reporting nonimmediate manifestations during penicillin therapy and to evaluate the diagnostic potential of patch tests, delayed-reading skin tests and challenges in such cases.
We used prick and intradermal tests as well as patch tests with penicillin determinants, ampicillin, amoxicillin and any other suspect penicillins. We also performed challenges with the suspect antibiotics.
Such antibiotics were aminopenicillins in 93.1% of 259 patients, most of whom had suffered from maculopapular rashes followed by piperacillin (4.2%). Three subjects displayed immediate skin test positivity. Ninety-four subjects showed patch test and delayed intradermal test positivity to the culprit penicillin (90 to aminopenicillins and 4 to piperacillin) and were considered as having had delayed hypersensitivity reactions. Five of the 8 subjects who displayed delayed intradermal test positivity and patch test negativity to the suspect penicillin underwent challenges, 2 reacted positively to the responsible aminopenicillin. Among the remaining 154 with negative results in allergologic tests, 125 agreed to undergo challenges; only 3 reacted. In all, 98 patients -- 93 of whom had experienced maculopapular rashes -- displayed delayed hypersensitivity (94 to aminopenicillins and 4 to piperacillin).
Both patch and intradermal tests are useful in evaluating nonimmediate reactions to penicillins, particularly maculopapular rashes. Patch test and delayed intradermal positivity together indicate delayed hypersensitivity. Intradermal testing appears to be slightly more sensitive than patch testing.
斑丘疹和荨麻疹样皮疹是青霉素治疗期间常见的非速发型表现;前者通常代表细胞介导的超敏反应。我们的目的是评估在青霉素治疗期间出现非速发型表现的成人的过敏发生率,并评估斑贴试验、延迟读数皮肤试验及激发试验在此类病例中的诊断潜力。
我们采用了点刺试验、皮内试验以及使用青霉素决定簇、氨苄西林、阿莫西林和任何其他可疑青霉素进行斑贴试验。我们还对可疑抗生素进行了激发试验。
在259例患者中,93.1%的此类抗生素为氨基青霉素,其中大多数患者出现斑丘疹,其次是哌拉西林(4.2%)。3名受试者皮肤试验即刻呈阳性。94名受试者斑贴试验和皮内试验延迟读数对致病青霉素呈阳性(90例对氨基青霉素呈阳性,4例对哌拉西林呈阳性),被认为发生了迟发型超敏反应。在8名对可疑青霉素皮内试验延迟读数呈阳性但斑贴试验呈阴性的受试者中,有5名接受了激发试验,2名对相关氨基青霉素反应呈阳性。在其余154名过敏试验结果为阴性的受试者中,125名同意接受激发试验;只有3名有反应。总共有98例患者——其中93例曾出现斑丘疹——表现出迟发型超敏反应(94例对氨基青霉素呈阳性,4例对哌拉西林呈阳性)。
斑贴试验和皮内试验均有助于评估对青霉素的非速发型反应,尤其是斑丘疹。斑贴试验和皮内试验延迟读数呈阳性共同表明迟发型超敏反应。皮内试验似乎比斑贴试验稍敏感。